These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 32610630)
21. Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease. Muraleedharan A; Ray SK Brain Sci; 2024 Jan; 14(1):. PubMed ID: 38275516 [TBL] [Abstract][Full Text] [Related]
22. Gut Microbiota is an Impact Factor based on the Brain-Gut Axis to Alzheimer's Disease: A Systematic Review. Zou B; Li J; Ma RX; Cheng XY; Ma RY; Zhou TY; Wu ZQ; Yao Y; Li J Aging Dis; 2023 Jun; 14(3):964-1678. PubMed ID: 37191418 [TBL] [Abstract][Full Text] [Related]
23. [A role of human microbiota in the development of neurodegenerative diseases]. Epishina IV; Budanova EV Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):57-65. PubMed ID: 36279229 [TBL] [Abstract][Full Text] [Related]
24. The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer's Disease. Köhler CA; Maes M; Slyepchenko A; Berk M; Solmi M; Lanctôt KL; Carvalho AF Curr Pharm Des; 2016; 22(40):6152-6166. PubMed ID: 27604604 [TBL] [Abstract][Full Text] [Related]
25. The role of gut microbiota in pathogenesis of Alzheimer's disease. Bostanciklioğlu M J Appl Microbiol; 2019 Oct; 127(4):954-967. PubMed ID: 30920075 [TBL] [Abstract][Full Text] [Related]
26. Microbiota Alterations in Alzheimer's Disease: Involvement of the Kynurenine Pathway and Inflammation. Garcez ML; Jacobs KR; Guillemin GJ Neurotox Res; 2019 Aug; 36(2):424-436. PubMed ID: 31089885 [TBL] [Abstract][Full Text] [Related]
27. The Gut Microbiota-Brain Axis: A New Frontier on Neuropsychiatric Disorders. Queiroz SAL; Ton AMM; Pereira TMC; Campagnaro BP; Martinelli L; Picos A; Campos-Toimil M; Vasquez EC Front Psychiatry; 2022; 13():872594. PubMed ID: 35722583 [TBL] [Abstract][Full Text] [Related]
28. Microbiota-gut-brain axis and Alzheimer's disease: Implications of the blood-brain barrier as an intervention target. Liu S; Gao J; Liu K; Zhang HL Mech Ageing Dev; 2021 Oct; 199():111560. PubMed ID: 34411603 [TBL] [Abstract][Full Text] [Related]
29. Manipulation of the diet-microbiota-brain axis in Alzheimer's disease. Lee D; Lee VM; Hur SK Front Neurosci; 2022; 16():1042865. PubMed ID: 36408394 [TBL] [Abstract][Full Text] [Related]
30. Alzheimer's disease and gut microbiota. Hu X; Wang T; Jin F Sci China Life Sci; 2016 Oct; 59(10):1006-1023. PubMed ID: 27566465 [TBL] [Abstract][Full Text] [Related]
31. Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway. Haran JP; Bhattarai SK; Foley SE; Dutta P; Ward DV; Bucci V; McCormick BA mBio; 2019 May; 10(3):. PubMed ID: 31064831 [TBL] [Abstract][Full Text] [Related]
32. Prebiotic Effect of Fructooligosaccharides from Chen D; Yang X; Yang J; Lai G; Yong T; Tang X; Shuai O; Zhou G; Xie Y; Wu Q Front Aging Neurosci; 2017; 9():403. PubMed ID: 29276488 [TBL] [Abstract][Full Text] [Related]
34. Time to test antibacterial therapy in Alzheimer's disease. Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495 [TBL] [Abstract][Full Text] [Related]
35. The role of neurovascular unit damage in the occurrence and development of Alzheimer's disease. Liu X; Hou D; Lin F; Luo J; Xie J; Wang Y; Tian Y Rev Neurosci; 2019 Jul; 30(5):477-484. PubMed ID: 30530893 [TBL] [Abstract][Full Text] [Related]
37. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota. Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623 [TBL] [Abstract][Full Text] [Related]
38. Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease. Naseer MI; Bibi F; Alqahtani MH; Chaudhary AG; Azhar EI; Kamal MA; Yasir M CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):305-11. PubMed ID: 24059313 [TBL] [Abstract][Full Text] [Related]
39. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics. Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754 [TBL] [Abstract][Full Text] [Related]